Abstract
Background: Being overweight and obese increases oxidative stress in the body. To test the hypothesis that genetic variations in oxidative stress pathway genes modifies the relationship between body mass index (BMI) and risk of non-Hodgkin lymphoma (NHL), we conducted a population-based case-control study in Connecticut women.
Methods: Individuals who were overweight/obese (BMI > 25) were compared to normal and underweight individuals (BMI < 25) and their risk of NHL stratified assuming a dominant allele model for each oxidative stress pathway SNP.
Results: Polymorphisms in AKR1A1, AKR1C1, AKR1C3, CYBA, GPX1, MPO, NCF2, NCF4, NOS1, NOS2A NOS3, OGG1, ATG9B, SOD1, SOD2, SOD3, RAC1 and RAC2 genes after false discovery rate (FDR) adjustment did not modify the association between BMI and risk of NHL overall and histological subtypes.
Conclusions:
The results suggest that common genetic variations in oxidative stress genes do not modify the relationship between BMI and risk of NHL. 
Methods
The study population(6, 7) and genotyping(5) have been described in detail elsewhere. Cases were histologically confirmed incident cases at Yale cancer center (ICD-O, M-9590-9642, 9690-9701, 9740-9750). To estimate risk of NHL, odds ratios (OR) and 95% confidence intervals were estimated using unconditional logistic regression adjusting for age (continuous), race (white, other), caloric intake (daily average), smoking (pack-years), and alcohol consumption (lifetime). Wald chi-square for the interaction term between BMI and genotype were reported with adjustment for multiple comparisons by FDR where a q-value of < 0.20 was considered significant (8) .
Results
Selected characteristics were presented in Table 1 . Histologies for cases were predominantly Bcell (79.34%), followed by T-cell (7.53%) and other (4.44%). Age, race and alcohol consumption were similarly distributed between cases and controls (P-value: 0.50, 0.24, and 0.48 respectively).
Compared to controls, cases were more likely to have been regular smokers (P-value: 0.028), consumed more calories (P-value: 0.037) and have a greater BMI (P-value: 0.0413) than controls.
Odds ratios of NHL risk comparing >25 BMI versus <25 BMI stratified by SNP genotype are presented in (Supplementary Table 1 ). Although significant risks of NHL were associated with overweight/obesity compared to normal weight among certain genotypes, no effect modification 
Conclusions
In this analysis, SNPs in oxidative stress pathway genes did not modify the relationship between BMI and NHL risk. This study was a population-based case-control study with histologically confirmed cases of NHL and accurate genotyping. The primary limitation of the study was the modest sample size for NHL subtype analyses. Additionally, 123 SNPs in 18 oxidative stress pathway genes were assessed. It is possible that unassessed polymorphisms in these genes or other oxidative stress pathway genes could modify the association between BMI and NHL risk.
Future full genomic scans with larger populations can elucidate further information on potential associations. Several polymorphisms (i.e. SOD2, GPX1, NOS2, AKR1A1, CYBA) associated with NHL risk in previous studies were not found to modify the association of NHL and BMI.
These results suggest that the additional oxidative stress caused by polymorphisms may not modify the effect of BMI on NHL risk.
